TITLE

Use, perceptions, and acceptability of a ready-to-use supplementary food among adult HIV patients initiating antiretroviral treatment: a qualitative study in Ethiopia

AUTHOR(S)
Olsen, Mette Frahm; Tesfaye, Markos; Kaestel, Pernille; Friis, Henrik; Holm, Lotte
PUB. DATE
June 2013
SOURCE
Patient Preference & Adherence;2013, Vol. 7, p481
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: Ready-to-use supplementary foods (RUSF) are used increasingly in human immunodeficiency virus (HIV) programs, but little is known about how it is used and viewed by patients. We used qualitative methods to explore the use, perceptions, and acceptability of RUSF among adult HIV patients in Jimma, Ethiopia. Methods: The study obtained data from direct observations and 24 in-depth interviews with HIV patients receiving RUSF. Results: Participants were generally very motivated to take RUSF and viewed it as beneficial. RUSF was described as a means to fill a nutritional gap, to "rebuild the body," and protect it from harmful effects of antiretroviral treatment (ART). Many experienced nausea and vomiting when starting the supplement. This caused some to stop supplementation, but the majority adapted to RUSF. The supplement was eaten separately from meal situations and only had a little influence on household food practices. RUSF was described as food with "medicinal qualities," which meant that many social and religious conventions related to food did not apply to it. The main concerns about RUSF related to the risk of HIV disclosure and its social consequences. Conclusion: HIV patients view RUSF in a context of competing livelihood needs. RUSF intake was motivated by a strong wish to get well, while the risk of HIV disclosure caused concerns. Despite the motivation for improving health, the preservation of social networks was prioritized, and nondisclosure was often a necessary strategy. Food sharing and religious fasting practices were not barriers to the acceptability of RUSF. This study highlights the importance of ensuring that supplementation strategies, like other HIV services, are compatible with the sociocultural context of patients.
ACCESSION #
89521576

 

Related Articles

  • Introduction. Murphy, Robert L. // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS95 

    Discusses the challenges faced by clinicians in choosing an effective treatment regimen for patients with HIV infections. Decrease in the success rate and sustained treatment response to second-line therapies in clinics; Need to find effective treatment options that have favorable...

  • HIV Care and General Internal Medicine. Cofrancesco, Joseph; Wu, Albert W. // JGIM: Journal of General Internal Medicine;Sep2001, Vol. 16 Issue 9, p638 

    Discusses the key challenges of treating HIV-positive patients. Recognition of the disease; Access to data on HIV-infected persons; Quality of care for HIV patients.

  • An HIV-Positive Patient Who Avoids Treatment. Legg, Jill J.; Goldschmidt, Ronald H. // American Family Physician;6/1/1999, Vol. 59 Issue 11, p3252 

    Comments on the case of an HIV-positive patient who avoids treatment. Reason for HIV-positive patients to avoid health care; Suggestions on how physicians can help HIV-positive patients go for treatment.

  • Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana A Randomized Clinical Trial. Baum, Marianna K.; Campa, Adriana; Shenghan Lai; Martinez, Sabrina Sales; Tsalaile, Lesedi; Burns, Patricia; Farahani, Mansour; Yinghui Li; van Widenfelt, Erik; Page, John Bryan; Bussmann, Hermann; Fawzi, Wafaie W.; Moyo, Sikhulele; Makhema, Joseph; Thior, Ibou; Essex, Myron; Marlink, Richard // JAMA: Journal of the American Medical Association;11/27/2013, Vol. 310 Issue 20, p2154 

    IMPORTANCE Micronutrient deficiencies occur early in human immunodeficiency virus (HIV) infection, and supplementation with micronutrients may be beneficial; however, its effectiveness has not been investigated early in HIV disease among adults who are antiretroviral therapy (ART) naive....

  • Adolescents and HIV in Sub-Saharan Africa: A Timely Issue and Missed Opportunity. Coovadia, Hoosen; Mantell, Joanne E. // Clinical Infectious Diseases;10/1/2010, Vol. 51 Issue 7, p852 

    The authors comment on issue related to the management of adult patients in Sub-Saharan, Africa who were infected with human immunodeficiency virus (HIV). They cite the context of the article by Ferrand and colleagues which focuses on the undiagnosed cases of HIV among adults living in the...

  • Implications of HIV Disease for Oral Health Services. Robinson, P. G. // Advances in Dental Research;Apr2006, Vol. 19 Issue 1, p73 

    This paper, by means of a quality framework, reviews health services research in relation to people with HIV infection. The relevance of oral health care services to people's needs is considered in terms of the goal of health services to reduce the burden of disease on the everyday life of the...

  • HIV clinical trials are not enough. Millson, Margaret E.; Rachlis, Anita R. // CMAJ: Canadian Medical Association Journal;3/09/99, Vol. 160 Issue 5, p669 

    Editorial. Discusses antiretroviral drug regimens for HIV infection. The paradigm of HIV therapy being complete suppression of viral replication to preserve and restore immune function and to delay or prevent the emergence of drug resistance; Reference to a study by Robert S. Hogg and...

  • Activity of the Combination of Nelfinavir and Saquinavir Against Human Immunodeficiency Virus After Failure of Prior Protease Inhibitor Therapy. Kravcik, Stephen; Victor, Gary; Angel, Jonathan B.; Badley, Andrew D.; Cameron, D. William // Clinical Infectious Diseases;9/1/1999, Vol. 29 Issue 3, p702 

    Reports on the effectiveness of combining nelfinavir and saquinavir for the treatment of HIV infections. Details of a retrospective study on HIV-positive patients prescribed with nelfinavir and saquinavir; Effects of the drugs on the viral levels of the patients; Importance of treatment changes...

  • Management of the Adverse Effects of Antiretroviral Therapy and Medication Adherence. Max, Blake; Sherer, Renslow // Clinical Infectious Diseases;6/1/2000 Supplement 2, Vol. 30, pS96 

    Examines the therapeutic agents included in the highly active antiretroviral therapy (HAART) for the treatment of patients with HIV infections. Link between poor adherence and failure of antiretroviral therapy; Threat of short term-adverse effects to successful introduction and maintenance of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics